Effect of normalization of hematocrit on brain circulation and metabolism in hemodialysis patients

Journal of the American Society of Nephrology

Volumn 10, Issue 4, 1999, Pages 854-863

  Metry, George ^a   Wikström, BJÖRN ^a   Valind, Sven ^a   Sandhagen, Bo ^a   Linde, TORBJÖRN ^a   Beshara, Soheir ^a   Långström, Bengt ^a   Danielson, Bo G ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; ANEMIA; ARTICLE; BLOOD RHEOLOGY; BLOOD VISCOSITY; BRAIN BLOOD FLOW; BRAIN BLOOD VOLUME; BRAIN CIRCULATION; BRAIN METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROCYTE AGGREGATION; FEMALE; HEMATOCRIT; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEMOGLOBIN DETERMINATION; HUMAN; MALE; PLASMA VISCOSITY; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TISSUE OXYGENATION; TREATMENT OUTCOME;

EID: 0033022449     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/asn.v104854     Document Type: Article

References (36)

1. Pascual J, Teruel J, Moya J, Liano F, Jimenez-Mena M, Ortuno J: Regression of left ventricular hypertrophy after partial correction of anemia with erythropoietin in patients on hemodialysis: A prospective study. Clin Nephrol 35: 280-287, 1991
2. Bárány P, Freyschuss U, Pettersson E, Bergstöm J: Treatment of anemia in hemodialysis patients with erythropoietin: Long-term effect on exercise capacity. Clin Sci 84: 441-447, 1993
3. Grimm G, Stockenhuber F, Schneweiss B, Madl C, Zeitlhofer J, Schneider B: Improvement of brain function in hemodialysis treated with erythropoietin. Kidney Int 38: 480-486, 1990
4. Walls J: Hemoglobin: Is more better? Nephrol Dial Transplant 10[Suppl 2]: 56-61, 1995
5. Churchill D, Muirhead N, Goldstein M, Posen G, Fay W, Beecroft M, Gorman J, Taylor D: Probability of thrombosis of vascular access among hemodialysis patients treated with recombinant human erythropoietin. J Am Soc Nephrol 4: 1809-1813, 1994
6. Radermacher J, Koch K: Treatment of renal anemia by erythropoietin substitution. Clin Nephrol 44[Suppl 1]: S56-S60, 1995
7. Eschbach J, Glenny R, Robertson T, Guthrie M, Rader B, Evans R, Chandler W, Davidson R, Easterling T, Denney J, Schneider G: Normalising the hematocrit (Hct) in hemodialysis patients (HDP) with EPO improves quality of life (Q/L) and is safe [Abstract]. J Am Soc Nephrol 4: 425, 1993
8. 15O and positron emission tomography. J Cereb Blood Flow Metab 1: 421-426, 1987
9. 15O. I. Theory and error analysis. J Nucl Med 24: 782-789, 1983
10. 15O and positron emission tomography: Theory, procedure and normal values. J Comp Assist Tomogr 4: 727-736, 1980
11. Sandhagen B: Analysis of hemorheological variables: Methodology and reference values. Uppsala J Med Sci 94: 81-87, 1989
12. Richardson T, Guyton A: Effects of polycythemia and anemia on cardiac output and other circulatory factors. Am J Physiol 197: 1167-1170, 1959
13. Guyton A, Richardson T: Effect of hematocrit on venous return. Circ Res 9: 157-164, 1961
14. Fischer T, Stohr-Lissen M, Schmid-Schönbein H: The red cell as a fluid droplet: Tank tread-like motion of the human erythrocyte membrane in shear flow. Science 202: 894-896, 1978
15. Motthaghy K, Haest C, Cremer J, Derissen W: Oxygen uptake into the sheared flowing blood: Effects of red cell membranes and hematocrit. Adv Exp Med & Biol 169: 175-185, 1984
16. Herscovitch P: Evaluation of the brain by positron emission tomography. Rheum Dis Clin North Am 19: 765-794, 1993
17. Hirakata H, Yao H, Osato S, Ibayashi S, Onoyama K, Otsuka M, Ichiya Y, Kuwabara Y, Masuda Y, Fujishima M: CBF and oxygen metabolism in hemodialysis patients: Effects of anemia correction with recombinant human EPO. Am J Physiol 262: F737-F743, 1992
18. Konobu K, Tomoko M, Yamamoto E, Sawanishi K: Inhibitory effect of uremic fluorescent substances on the cellular energy generation. Nippon Jinzo Gakkai Shi 31: 105-109, 1989
19. Radda G, Odoom J, Kemp G, Taylor D, Thompson C, Styles P: Assessment of mitochondrial function and control in normal and diseased states. Biochim Biophys Acta 1271: 15-19, 1995
20. Sokoloff L: Relationships among local functional activity, energy metabolism and blood flow in the central nervous system. Fed Proc 40: 2311-2316, 1981
21. Tu Y-K, Liu H-M: Effects of isovolemic hemodilution on hemodynamics, cerebral perfusion, and cerebral vascular reactivity. Stroke 27: 441-445, 1996
22. Johnson W, McCarthy J, Yanagihara T, Osmundson P, Ilstrup D, Jenson B, Walter Bowie E: Effects of recombinant human erythropoietin on cerebral and cutaneous blood flow and on blood coagulability. Kidney Int 38: 919-924, 1990
23. Brown M, Wade J, Marshall J: Fundamental importance of arterial oxygen content in the regulation of cerebral blood flow in man. Brain 108: 81-93 1985
24. Kogure K, Scheinberg P, Reinmuth O, Fujishima M, Bustro R: Mechanisms of cerebral vasodilatation in hypoxia. J Appl Physiol 29: 223-229, 1970
25. Powers W: Positron emission tomography in the evaluation of cerebrovascular disease: Clinical applications? In: Clinical Neuroimaging, edited by Theodore WH, New York, Alan R. Liss, 1988, pp 49-60
26. Leenders K, Perani D, Lammertsma A, Heather J, Buckingham P, Healy M, Gibbs J, Wise R, Hatazawa J. Herold S, Beaney R. Beooks D, Spinkes T, Rhodes C, Frackowiak R, Jones T: Cerebral blood flow, blood volume and oxygen utilisation: Normal values and effect of age. Brain 113: 27-47, 1990
27. Reed G, Devous M: Southwestern Internal Medicine Conference: Cerebral blood flow autoregulation and hypertension. Am J Med Sci 289: 37-44, 1985
28. Aaslid R, Lindegaard K, Sorteberg W, Nornes H: Cerebral autoregulation dynamics in humans. Stroke 20: 45-52, 1989
29. Gibbs J, Wise R, Leenders K, Jones T: Evaluation of cerebral perfusion reserve in patients with carotid-artery occlusion. Lancet 1: 310-314, 1984
30. Schäbitz VJ: The importance of rheology in internal medicine. Z Gesamte Inn Med 37: 372-378, 1982
31. Klitzman B: Rheology and the regulation of oxygen delivery. Microsurgery 15: 369-373, 1994
32. Yigitoglu M, Polat M, Akcay F, Ari Z, Uyanik B, Ozilgili H: Increased lipoprotein (a) and its relationships with other parameters of lipoprotein metabolism in chronic renal failure treated by hemodialysis. Jpn Heart J 38: 83-89, 1997
33. Grotta J, Ostrow P, Fraifeld E, Hartmann D, Gary H: Fibrinogen, blood viscosity and cerebral ischemia. Stroke 16: 192-198, 1985
34. Bárány P, Svedenhab J, Freyschuss U, Bergström J: Physiological effects of correcting anemia in hemodialysis patients to a normal hemoglobin concentration [Abstract]. Clin Invest 12: 5, 1994
35. Nissenson A, Pickett J, Theberge D, Brown W, Schweitzer S: Brain function is better in hemodialysis patients when hematocrit is normalized with erythropoietin [Abstract]. J Am Soc Nephrol 7: 1459, 1996
36. Hino A, Ueda S, Mizukawa N, Imahori Y, Tenjin H: Effect of hemodilution on cerebral hemodynamics and oxygen metabolism. Stroke 23: 423-426, 1992